Literature DB >> 7931272

Structural determinants of the Alzheimer's amyloid beta-peptide.

C Soto1, M C Brañes, J Alvarez, N C Inestrosa.   

Abstract

The hallmark event of Alzheimer's disease (AD) is the deposition of amyloid as insoluble fiber masses in extracellular neuritic plaques and around the walls of cerebral blood vessels. The main component of amyloid is a hydrophobic peptide, named amyloid beta-peptide (beta A4), which results from the processing of a much longer membrane amyloid precursor protein (APP). This review focuses on the structural features of beta A4 and the factors that determine beta A4 insolubilization. Theoretical and experimental studies of the primary structure of beta A4 have shown that it is composed of a completely hydrophobic C-terminal domain, which adopts beta-strand structure, and an N-terminal region, whose sequence permits different secondary structures. In fact, this region can exist as an alpha-helical or beta-strand conformation depending on the environmental condition (pH and hydrophobicity surrounding the molecule). The effects of pH and hydrophobicity on beta A4 structure may elucidate the mechanisms determining its aggregation and amyloid deposition in AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931272     DOI: 10.1046/j.1471-4159.1994.63041191.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

Review 1.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

Authors:  N C Inestrosa; M P Marzolo; A B Bonnefont
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

2.  Metal cations defibrillize the amyloid beta-protein fibrils.

Authors:  V P Chauhan; I Ray; A Chauhan; J Wegiel; H M Wisniewski
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

Review 3.  Posttranslational arginylation of brain proteins.

Authors:  M E Hallak; G Bongiovanni
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

4.  Effects of polyprenols from pine needles of Pinus massoniana on ameliorating cognitive impairment in a D-galactose-induced mouse model.

Authors:  Cong Wang; Ling He; Ming Yan; Guang-yao Zheng; Xiao-yang Liu
Journal:  Age (Dordr)       Date:  2014-07-01

5.  A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.

Authors:  Panchanan Maiti; Tia C Hall; Leela Paladugu; Nivya Kolli; Cameron Learman; Julien Rossignol; Gary L Dunbar
Journal:  Histochem Cell Biol       Date:  2016-07-12       Impact factor: 4.304

Review 6.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

7.  Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides.

Authors:  E O Campos; A Alvarez; N C Inestrosa
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

8.  Binding of amyloid beta-protein to intracellular brain proteins in rat and human.

Authors:  I Ray; A Chauhan; H M Wisniewski; J Wegiel; K S Kim; V P Chauhan
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

9.  Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures.

Authors:  Qiang Liu; Baolu Zhao
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

10.  Role of synucleins in Alzheimer's disease.

Authors:  Leslie Crews; Igor Tsigelny; Makoto Hashimoto; Eliezer Masliah
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.